About Securecell
Securecell is a company based in Zurich (Switzerland) founded in 2009. Securecell offers products and services including Lucullus Bioprocess Software Solution, Numera Advanced Bioprocess Sampling, Integra1 E2E End-To-End Bioprocessing, Seraccess AXM Automated Blood Monitoring, and Seraccess SENSE Artificial Pancreas Device. Securecell operates in a competitive market with competitors including Dexcom, Livongo, One Drop, Bigfoot Biomedical and GSK, among others.
- Headquarter Zurich, Switzerland
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website securecell.ch
- Social LinkedIn YouTube
- Legal Name Securecell Ag
Products & Services of Securecell
Securecell offers a comprehensive portfolio of products and services, including Lucullus Bioprocess Software Solution, Numera Advanced Bioprocess Sampling, Integra1 E2E End-To-End Bioprocessing, Seraccess AXM Automated Blood Monitoring, and Seraccess SENSE Artificial Pancreas Device.
Software for managing and optimizing bioprocess workflows.
Tools for advanced sampling in bioprocessing applications.
System for comprehensive end-to-end bioprocess development.
Device for automated monitoring of critical blood parameters.
Device for personalized glucose control in patients.
Apps and channels of Securecell
its YouTube channel Securecell AG has 50 subscribers and 23 videos.
Videos from Securecell
The most watched videos on Securecell's YouTube channel, Securecell AG (50 subscribers). Click a video to play it here.
More on Securecell AG.
People of Securecell
1 people are tracked at Securecell (1 in leadership).
| Name | Role | Group |
|---|---|---|
Carlo Andretta | CEO | Leadership |
Complete people profiles for Securecell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Securecell
Securecell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, Bigfoot Biomedical and GSK, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $245.2M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions | |
| bigfootbiomedical.com | 2014 | Milpitas, United States | $214.51M | 133 | Developer of a closed-loop automated insulin delivery system | |
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| mysugr.com | 2012 | Vienna, Austria | $4.8M | – | Gamified apps for diabetes management and therapy are provided. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of Securecell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Securecell
The website of Securecell (securecell.ch) receives about 6.8K visits a month.
- Monthly visits6.8K
▲ 44.7% vs previous month
Websites whose visitors overlap most with Securecell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
software-job.ch | software-job.ch | 100% | – | #2,195,274 | – |
Latest news on Securecell
Complete news archive for Securecell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Securecell
10 companies that operate in the same segment as Securecell (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Securecell
Securecell was founded in 2009.
Securecell is headquartered in Zurich, Switzerland.
Securecell was founded in 2009 in Zurich, Switzerland, where bioprocessing solutions are developed for the biotechnology sector. The Lucullus Process Information Management System is utilized for planning, executing, monitoring, and evaluating bioprocesses in various companies. PAT solutions are provided for sample transport, automated processing, high-precision measurement, and integrated gas component analysis in process environments. Operations focus on enhancing bioprocess efficiency through these integrated technologies.
Securecell's top competitors include Dexcom, Sutro Biopharma and Bigfoot Biomedical.
Securecell offers Lucullus Bioprocess Software Solution, Numera Advanced Bioprocess Sampling, Integra1 E2E End-To-End Bioprocessing, Seraccess AXM Automated Blood Monitoring, and Seraccess SENSE Artificial Pancreas Device.
Securecell operates through Securecell Ag.